SCHEMBL30499343

SCHEMBL30499343

CN1CCN(C(N)=O)C(c2ccccn2)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.42
HHAT Q5VTY9 1/20 0.42
ALDH1A1 P00352 1/20 0.41
CASP1 P29466 1/20 0.41
CYP1A2 P05177 1/20 0.39
CHRM2 P08172 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
CYP2D6 P10635 1/20 0.39
CHRM1 P11229 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
DRD1 P21728 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTR7 P34969 1/20 0.39
ADRA1A P35348 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38659451 0.79 HSD11B1 (0.51) RIPK1ALDH1A1NPC1RAB9APRMT5
SCHEMBL8296762 0.79 HSD11B1 (0.51) RIPK1ALDH1A1NPC1RAB9APRMT5
SCHEMBL31430923 0.78 PRMT5 (0.55) RIPK1ALDH1A1NPC1RAB9APRMT5
SCHEMBL29504572 0.78 PRMT5 (0.55) RIPK1ALDH1A1NPC1RAB9APRMT5
SCHEMBL29939211 0.77 RIPK1 (0.41) RIPK1HHATALDH1A1CASP1TSHR
SCHEMBL29933840 0.77 PIK3C3 (0.41) RIPK1HHATALDH1A1CASP1NPC1
SCHEMBL5321655 0.76 RIPK1 (0.40) RIPK1HHATHTR2AHTR2CHTR7
SCHEMBL30398913 0.76 CDK5 (0.40) RIPK1HHATALDH1A1CASP1DRD3
SCHEMBL31276032 0.72 NPC1 (0.38) ALDH1A1CYP1A2CHRM2HTR1AADRA2A
SCHEMBL20236634 0.72 HTR1A (0.47) HHATALDH1A1CASP1HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116096719-A Pyridazinylamino derivatives as ALK5 inhibitors 奇斯药制品公司 2023-05-09 CN disclosed